Cargando...

Strategies for Predicting Response to Checkpoint Inhibitors

PURPOSE OF REVIEW: Despite the clinical successes of immune checkpoint blockade across multiple tumor types, many patients do not respond to these therapies or become resistant after an initial response. This underscores the need to improve our understanding of the molecular determinants of response...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Curr Hematol Malig Rep
Main Authors: Zappasodi, Roberta, Wolchok, Jedd D., Merghoub, Taha
Formato: Artigo
Idioma:Inglês
Publicado: 2018
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6719799/
https://ncbi.nlm.nih.gov/pubmed/30159703
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11899-018-0471-9
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!